This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nehler, M. R Articles by Regensteiner, J. G Search for Related Content PubMed PubMed Citation Articles by Nehler, M. R Articles by Regensteiner, J. G Social Bookmarking                   What's this?

Functional outcomes and quality of life in peripheral arterial disease: current status

Sections of Vascular Surgery, Departments of Surgery and Medicine, University of Colorado Health Sciences Center, Denver, CO, USA, mark.nehler{at}uchsc.edu

Mary M McDermott

Feinberg School of Medicine at Northwestern University, Chicago, IL, USA

Diane Treat-Jacobson

School of Nursing, University of Minnesota, Minneapolis, MN, USA

Ian Chetter

Department of Vascular Surgery, The Queen Elizabeth Hospital, Adelaide, South Australia

Judith G Regensteiner

Section of Medicine, Department of Surgery and Medicine, University of Colorado Health Sciences Center, Denver, CO, USA

This review examines current evidence for baseline functional impairment and changes with therapy in patients with peripheral arterial disease (PAD) - ranging from patients without claudication or critical limb ischemia (CLI) but other exertional leg symptoms (erroneously referred to as asymptomatic in the Fontaine classifi cation system), to patients with claudication and those with CLI. The review points out that the status of functional outcomes research is markedly different in focus and development in the different levels of disease severity - paradoxically less studied in the more severe CLI population than in patients with claudication, for example.

Key Words: critical limb ischemia • intermittent claudication • outcomes • peripheral arterial disease • quality of life

Vascular Medicine, Vol. 8, No. 2, 115-126 (2003)
DOI: 10.1191/1358863x03vm483ra


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Xing, J. Lu, and J. Li Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1380 - H1387. [Abstract] [Full Text] [PDF]

				I. Al Mheid and A. A. Quyyumi Cell Therapy in Peripheral Arterial Disease Angiology, January 1, 2009; 59(6): 705 - 716. [Abstract] [PDF]

				S. Rajagopalan, S. Dellegrottaglie, A. L. Furniss, B. W. Gillespie, S. Satayathum, N. Lameire, A. Saito, T. Akiba, M. Jadoul, N. Ginsberg, et al. Peripheral Arterial Disease in Patients With End-Stage Renal Disease: Observations From the Dialysis Outcomes and Practice Patterns Study (DOPPS) Circulation, October 31, 2006; 114(18): 1914 - 1922. [Abstract] [Full Text] [PDF]

				A. E. Aquarius, J. De Vries, D. P. V. B. Henegouwen, and J. F. Hamming Clinical indicators and psychosocial aspects in peripheral arterial disease. Arch Surg, February 1, 2006; 141(2): 161 - 166. [Abstract] [Full Text] [PDF]

				A. Chandiwal, V. Balasubramanian, Z. K. Baldwin, M. S. Conte, and L. B. Schwartz Gene Therapy for the Extension of Vein Graft Patency: A Review Vascular and Endovascular Surgery, January 1, 2005; 39(1): 1 - 14. [Abstract] [PDF]